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Abstract
As a source of biologically active compounds, buckwheat has benefi cial eff ects in nutrition due to its high content of fl avonoids, particularly 
rutin.
Aim of our study was to examine eff ects of buckwheat on plasma lipid status and phospholipids fatty acids composition, histological and 
parameters of oxidative stress in Wistar rats fed a high-fat diet. Th is study showed that buckwheat leaf and fl ower (BLF) mixture supplementa-
tion signifi cantly reduce weight gain, plasma lipid concentrations and atherogenic index in rats fed a high-fat diet. Treatment of the high-fat 
group of animals with buckwheat signifi cantly increased percentage of n- fatty acids as well as eicosapentaenoic acid (EPA) and decreased 
percentage of saturated fatty acids (SFA) and oleic acid. Buckwheat antioxidant eff ects diminished negative infl uence of high-fat diet in hy-
perlipidemic rats, while pathohistological analysis of liver confi rmed changes after high-fat consumption. Our results showed hypolipidemic, 
antiatherogenic and antioxidative features of buckwheat leaf and fl ower mixture, and these parts of the plant with the highest rutin content 
could be benefi cial in prevention and curing of hyperlipidemia.
 ©  Association of Basic Medical Sciences of FB&H. All rights reserved
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INTRODUCTION
Buckwheat (Fagopyrum esculentum) is a herbaceous plant, 
which belongs to the Polygonaceae family and is important 
food source which contains proteins with high biological 
value and balanced amino acid composition, fibres, vita-
mins B and B, zinc, copper, manganese and selenium []. 
Buckwheat grains and hulls contain components with heal-
ing properties and biological activity, such as fl avonoids and 
fl avon, phenolic acid, condensed tannins, phytosterols and 
fagopyrins. Flavonoids are phytonutrients with chelating 
properties, acting as antioxidants inhibiting lipid peroxida-
tion, chelate redox-active metals, and attenuate reactive 
oxygen species (ROS) damages []. Buckwheat’s fl avonoid 
compounds decrease blood cholesterol, helping the preven-
tion of a high blood pressure. In addition, buckwheat reduces 
cellular proliferation and therefore it protects the colon 
against carcinogenesis []. Th e antioxidant activity in buck-
wheat exhibited a statistically signifi cant relationship with its 
total phenolics, as well as rutin content []. Rutin, a fl avonoid 
composed of fl avonol quercetin and disaccharide rutinose, 
has anti-infl ammatory, hypotensive eff ect. Rutin/quercetin 
inhibits oxidation of lipoproteins, which suggests that rutin 
could reduce the risk for arteriosclerosis []. Buckwheat seed 
contains more rutin than do most plants. Th e rutin content of 
the fl ower part is higher than that of other parts of the buck-
wheat (fl ower > leaves > seed > stem > root). About – of 
rutin per dry weight can be found in buckwheat fl owers and 
leaves, and their total phenolics content is higher than that of 
seeds []. Dietary fats can modulate the plasma phospholip-
ids fatty acid composition (FAs) []. Alterations in these lipid 
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classes are of special interest because plasma phospholipids 
(PL) mirror the tissue PL status and these functional and 
pathological consequences can be correlated []. Since di-
etary fat is one of the most important environmental factors 
associated with the cardiovascular diseases incidence, this 
study aimed to investigate hypolipidemic and antioxidant ef-
fects of buckwheat in rats fed a high-fat diet. Because, fatty 
acids (FAs) composition of PL highly correlates with dietary 
intake [], one of our aims was to examine eff ects of buck-
wheat supplementation in rats on FAs composition in PL.
MATERIALS AND METHODS
Plant material
Buckwheat (Fagopyrum esculentum – Moench) leaf and 
flower (BLF) parts in dried powder form were obtained 
from Institute for Medicinal Plants Research "Dr Josif 
Pančić", Belgrade, Serbia, where the voucher specimen 
(No. ) was deposited. Polyphenolic content of 
BLF mixture was: rutin ., quercetin ., hyperoside 
., gallic acid ., protocatechuic acid ., caffeic 
acid ., catechin . and chlorogenic acid . (wt/
wt), determined using high performance liquid chroma-
tography with diode-array detection (HPLC/DAD) []. 
Experimental animals and diets
Experiments were carried out on forty male Wistar rats, (four 
months aged, b.w. - g), obtained from the vivarium 
(Galenika a.d., Belgrade, Serbia). All the experiments and pro-
tocols employed in the study were reviewed and approved 
by the Institutional Animal Care and Use Committee [No. 
III--]. Experimental animals were housed in groups of 
two or three per standard cage, in a room with a  h light-
dark cycle and an ambient temperature of °C. All rats were 
fed a pellitized commercial chow diet for  weeks after arrival. 
Th ey were then randomly divided into fi ve groups. Th e ani-
mals of the group I (control) were fed normal chow (n=). 
Th e rats of the group II (buckwheat) were fed normal chow 
with  BLF mixture (n=). High-fat (HF) groups III and 
IV were fed a lipogenic diet [] consisting of . choles-
terol,  sunfl ower oil and . sodium cholate added to 
normal chow without (group III, n=) or with  BLF mix-
ture (group IV, n=). Th is regime was maintained  weeks. 
Th e animals of group V were maintained in the same food 
regime as the animals in group III (n=). After  weeks, the 
animals doubled plasma cholesterol concentration and they 
were maintained in the same food regime as the animals in 
group IV for  weeks. Th e composition of the experimental 
diet is shown in Table . Th e animals were given food and tap 
water ad libitum during the experimental period. Food con-
sumption and weight gain were measured daily and weekly, 
respectively. After ,  and  weeks of experiment, the ani-
mals were fasted overnight and then sacrifi ced under ether 
anesthesia. Blood samples (- ml) were collected from the 
inferior vena cava in tubes containing heparin, and plasma 
was separated for biochemical analysis. Th e livers were re-
moved, rinsed with saline and stored at - °C. Th e abdomi-
nal aorta, pieces of heart, liver, kidney and brain tissues were 
removed from the rats, rinsed with saline and fi xed in a buf-
fer solution of  formalin for the pathohistological analysis.
Biochemical analysis
Th e levels of plasma total cholesterol (TC) and triglycerides 
(TG), alanine transaminase (ALT) and aspartate transaminase 
(AST) were measured using the automated enzymatic meth-
ods (EliTech Diagnostic, Sees, France). Plasma high-density 
lipoprotein cholesterol (HDL) was measured after precipita-
tion with phosphotungstic acid and magnesium chloride []. 
Low-density lipoprotein cholesterol (LDL) was calculated us-
ing formula by Friedewald et al. []. Th e PL fraction was iso-
lated from the extracted lipids by one-dimensional thin layer 
chromatography (TLC) with neutral lipid solvent system of 
hexane-diethyl ether-μ acetic acid (::, v/v) using Silica 
Gel GF plates (C. Merck, Darmstadt, Germany). Th e extrac-
tion, preparation of FAs methyl esters and gas chromatogra-
phy (GC) analysis were performed as previously described 
[]. Comparing sample peak retention times with authentic 
standards (Sigma Chemical Co, St. Louis, MO, USA) and/
Component (%) I group II group III group IV group
Casein 20 20 20 20
Cellulose 5.5 5.5 5.5 5.5
Corn starch 15 15 15 15
Sucrose 53 48 30 25
Calcium 1.8 1.8 1.8 1.8
Phosphorus 0.8 0.8 0.8 0.8
Sodium 0.8 0.8 0.8 0.8
Zinc 0.04 0.04 0.04 0.04
Copper 0.003 0.003 0.003 0.003
Iron 0.05 0.05 0.05 0.05
Manganese 0.006 0.006 0.006 0.006
Iodine 0.0005 0.0005 0.0005 0.0005
Selenium 0.0005 0.0005 0.0005 0.0005
Antioxidant 0.05 0.05 0.05 0.05
Lysine 1 1 1 1
Methionine and cystine 0.95 0.95 0.95 0.95
Vitamin A 0.07 0.07 0.07 0.07
Vitamin D3 0.07 0.07 0.07 0.07
Vitamin E 0.8 0.8 0.8 0.8
Vitamin B12 0.06 0.06 0.06 0.06
Cholesterol - - 2.5 2.5
Sunfl ower oil - - 20 20
Sodium cholate - - 0.5 0.5
Buckwheat - 5 - 5
TABLE 1.  Composition of the experimental diets.
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or the PUFA- standard mixture (Supelco Inc., Belleforte, 
PA, USA) individual FAs methyl esters were identified.
Hepatic lipid peroxidation, antioxidant enzyme activities and 
free radical scavenging assays 
After partly defrosting, liver was homogenized on ice-cold in 
the mM phosphate buff er, pH . (buff er: tissue :(w/v). 
Homogenization was performed in homogenizer Ultra Turex 
(Janke Kinkel) []. Homogenized tissue was centrifuged at 
g for minutes at +°C and the activity of xanthine 
oxidase (XOD), catalase (CAT), glutathione S-transferase 
(GST) and other parameters of oxidative stress were mea-
sured in supernatant. Th e protein content was determined by 
the method of Bradford []. Activities of all determined en-
zymes were expressed in units per mg proteins (U/mg). XOD 
activity was assayed according to the Bergmayer method 
[]. CAT activity was determined according to Clairborne 
[]. GST activity was measured according to the Habig et al. 
[] method. Th e amount of the reduced glutathione (GSH) 
was measured after the homogenate precipitation with  
sulfosalicylic acid ( w/v) and its centrifugation at  
g for  min and, then, measured by the Ellman method []. 
Th e data are expressed as nmol of GSH per mg protein. Th e 
superoxide dismutase (SOD) and glutathione peroxidase 
(GSH-Px) activities were determined using commercially 
available kits (purchased from RANDOX Laboratories, An-
trim, United Kingdom). Th e malondialdehyde levels (MDA) 
were estimated by TBARS Assay Kit (Cayman Chemicals, 
USA). Th e antioxidant activity of the liver supernatants was 
measured on the basis of the radical scavenging ability us-
ing the stable radical, ,-diphenyl--picrylhydrazyl (DPPH) 
[-]. The DPPH radical scavenging activity () was cal-
culated as [- (sample absorbance /control absorbance)] 
× . The IC values (mg per liver tissue) denoted the 
amount of the sample, which was required to scavenge  
of the DPPH free radicals. Th e spectrophotometric assays 
were performed with a Nicolet Evolution  UV/VIS scan-
ning spectrophotometer equipped with a cell positioned or 
with a multi plate reader Th ermo LabSystem Multiskan EX.
Pathohistological analysis
Fixed tissues (aorta, heart, liver, kidney and brain) were 
processed routinely for paraffin embedding, and μm 
sections were prepared and stained with hematoxylin-
eosin, stained areas were viewed using an optical mi-
croscope with magnifying power of x  and x .
Statistical analysis
Th e results were expressed as mean values ± standard devia-
tion (SD). Th e statistical signifi cance was determined using 
one-way analysis of variance (ANOVA). Th e diff erences be-
tween control and experimental diets were determined by the 
Turkey’s test. Values of p<. were considered signifi cant.
RESULTS 
Food intake, weight gain and organ weights
Food intake was equivalent between all groups that al-
lows us to compare effects of BLF mixture (Table ). Af-
ter  weeks of the experiment, the body weight gain was 
significantly higher (p<.) in the group III compared to 
other groups of animals. The average weight gains of the 
IV and V group were not significantly different from that 
of the I and II group (p>.). However, the food effi  ciency 
ratio (FER) of the IV and V group exhibited similar values 
that appeared to be signifi cantly higher than of the I and II 
group (p<.). Compared with I, II, IV and V group, there 
was significantly higher FER in the III group of animals 
(p<.). Organ weights were expressed as their relative 
weight per body weight (Table ). The relative weight of 
heart was signifi cantly higher in the II group than in other 
groups (p<.). The relative weights of liver were signifi-
cantly higher in HF groups than in the I and II group (p<.). 
Plasma lipid levels and transaminase activities
Concentrations of plasma lipids and transaminase activities 
after ,  and  weeks of the experiment are shown in Ta-
ble . After  weeks, a signifi cant diff erence was observed in 
HDL levels, atherogenic index (AI), ALT and AST activities, 
Group I II III IV V
Food intake (g/day) 22.15±1.14a 20.35±1.58a 19.19±0.29a 18.51±1.04a 18.93±0.75a
Weight gain (g/day) 8.96±0.72a 7.22±0.82a 13.31±1.15b 9.75±0.73a 10.67±1.35a
FER* 0.40±0.07a 0.35±0.06a 0.69±0.10b 0.52±0.05c 0.55±0.08c
Organ weights (mg/g b.w.)
Heart 3.25±0.45a 3.58±0.26c 3.13±0.24a 3.24±0.11a 3.49±0.45a
Liver 30.17±2.37a 30.43±2.08a 46.69±3.71c 48.28±5.43c 48.29±4.04b
Kidney 4.39±0.16a 4.59±0.39a 3.94±0.3a 4.44±0.74a 4.11±0.27a
Brain 3.81±0.14a 4.33±0.50a 4.09±0.32a 4.22±0.74a 4.27±0.52a
TABLE 2.  Food intake, weight gain, and organ weights in control and experimental groups of rats.
Values are expressed as mean ± SD. * Food effi  ciency ratio: weight gain/food intake. a,b,c,d Means in the same row not sharing a common superscript are 
signifi cantly diff erent (p<0.05) between groups.
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while after  weeks a signifi cant diff erence was observed in 
all plasma lipid levels, AI and AST/ALT activities between I 
and III group. An increase in TC and AI by . and . 
respectively was observed in III group of animals. After that 
period, feeding regime was changed to the V group from a 
lipogenic diet to a lipogenic diet with BLF. In the next  
weeks the supplementation of BLF to the V group signifi cant-
ly lowered TG by ., TC by ., LDL by . and AI by 
. compared to the III group (p<.). Also, after  weeks 
the supplementation of BLF to the IV group signifi cantly low-
ered TG by ., TC by ., LDL by . and AI by . 
compared to the III group (p<.), which indicated that the 
BLF mixture had anti-hyperlipidemic eff ect. HDL concentra-
tion and transaminase activities were not signifi cantly diff er-
ent (p>.) between III, IV and V groups of animals. After  
weeks of the experiment there were no signifi cant diff erences 
in plasma lipid levels, AI and transaminase activities between 
I, II, IV and V group (p>.), except signifi cant diff erences 
observed in HDL and LDL levels comparing I and II with IV 
and V group (p<.). Compared with I and II group, there 
were signifi cant diff erences in all analyzed parameters in the 
III group of animals with induced hyperlipidemia (p<.). 
Fatty acid analysis
Results of FA analysis of PL (Table ) showed that the low-
est percentage of palmitic acid (:) was in V group, sig-
nificantly lower compared to all other examined groups. 
Percentage of stearic acid (:) significantly increased in 
group V compared to I and group III. Therefore, percent-
age of saturated fatty acids (SFA) decreased in group V 
compared to II, III and IV group. Our results showed that 
percentage of oleic acid (: n-) decreased in group V as 
Week Group TG (mmol/L) TC (mmol/L) HDL-c (mmol/L) LDL-c (mmol/L) AI* AST (IU/L) ALT (IU/L)
2
I 1.11±0.13a 1.17±0.08a 0.69±0.11a 0.26±0.05a 0.63±0.20a 177±29a 80.5±11a
III 0.45±0.23a 1.41±0.10a 0.34±0.03b 0.87±0.02a 3.17±0.64b 30±4b 128±11b
7
I 0.49±0.06a 1.17±0.06a 0.67±0.12a 0.28±0.05a 0.79±0.15a 193±33a 38±6a
III 0.19±0.04b 2.42±0.35b 1.19±0.21b 1.14±0.28b 3.57±0.58b 63±10b 67±31b
13
I 1.10±0.50a 1.54±0.16a 1.00±0.02a 0.09±0.02a 0.54±0.13a 130±14ab 66±5a
II 1.16±0.20a 1.49±0.18a 0.93±0.09a 0.14±0.05a 0.62±0.13a 122±18a 65±10ab
III 0.92±0.35b 2.66±0.76b 1.29±0.21b 0.95±0.20b 1.04±0.29b 154±41b 82±9b
IV 0.81±0.19a 1.92±0.21a 1.19±0.04b 0.37±0.08c 0.62±0.15a 151±25ab 80±1ab
V 0.55±0.12a 1.97±0.18a 1.43±0.22b 0.30±0.07c 0.41±0.27a 155±23ab 82±13ab
TABLE 3.  Biochemical parameters in plasma of control and experimental groups of rats.
Values are expressed as mean ± SD. *Atherogenic index (AI): (TC-HDL-c)/HDL-c. a,b,c Means in the same column and time period not sharing a common 
superscript are signifi cantly diff erent (p<0.05) between groups.
Fatty acid (%) I group II group III group IV group V group
16:0 29.01±0.63 25.79±0.80**c,d,g 30.80±0.36i 29.79±2.33i 22.09±0.94***
18:0 22.55±0.38 32.97±1.85***c,d 26.17±0.73***f,i 30.54±0.86*** 31.04±0.28***
SFA 51.88±0.73 58.76±1.20***i 56.97±0.50***e,h 60.33±1.77***i 53.13±0.66
16:1 n-7 1.22±0.79 1.39±0.60 1.90±0.17 1.23±0.19 1.29±0.20
18:1 n-9 12.25±0.85 5.64±1.88***c,f 14.73±0.53*d,i 11.96±0.67i 6.98±0.39***
18:1 n-7 2.67±0.24 2.13±0.16 1.47±0.26** 1.77±0.74* 1.67±0.07*
MUFA 16.13±1.43 9.16±2.52***c,d 18.10±0.68i 14.97±0.54i 9.88±0.66***
18:2 n-6 12.58±0.82 13.24±2.02 11.72±0.58 10.51±1.36 14.67±0.16
20:3 n-6 0.60±0.07 0.98±0.18** 1.23±014*** 1.01±0.16** 1.37±0.20***
20:4 n-6 12.30±0.31 12.94±2.52c,d 7.16±0.19***i 7.70±0.18***i 14.63±1.00
22:4 n-6 0.27±0.02 0.68±0.10***c,f 1.56±0.07***i 1.40±0.18***i 0.91±0.09***
n-6 25.75±0.94 27.85±0.83*c,d,h 21.68±0.60***i 20.63±1.13***i 31.57±1.06***
18:3 n-3 0.32±0.09 0.35±0.10 0.50±0.05 0.33±0.15 0.31±0.09
20:5 n-3 0.28±0.07 0.88±0.61i 0.21±0.06i 0.48±0.31i 2.50±0.14***
22:5 n-3 0.82±0.15 0.59±0.29 0.50±0.05 0.69±0.13 0.49±0.13
22:6 n-3 4.88±0.18 2.41±0.55*** 1.89±0.44*** 2.25±0.54*** 2.11±0.09***
n-3 6.12±0.24 4.24±1.18** 3.10±0.44***h 3.64±0.64** 5.41±0.27
n-6/n-3 4.32±0.25 6.92±1.89** 7.11±1.23** 5.75±0.82 5.83±0.09
PUFA 31.72±0.95 32.08±1.97c,f,h 24.78±0.52***i 24.28±1.69***i 36.99±1.32***
TABLE 4.  Plasma phospholipids fatty acids profi les in control and experimental groups of rats.
ANOVA - one way variance, statistical signifi cance, *p <0.05, ** p <0.01, *** p <0.001 v.s. group III a- p <0.05, b- p <0.01, c- p <0.001; v.s. group IV 
d- p <0.05, e- p <0.01, f- p <0.001; v.s. group V g- p <0.05, h- p<0.01, i- p<0.001.
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FIGURE 1.  DPPH (IC50) (A) and MDA (B) levels in control and experimental groups of rats. Values are expressed as mean ± SD. Means with 
the same letters are not signifi cantly diff erent at p<0.05.
FIGURE 2.  XOD (A), CAT (B), SOD (C), GSH-Px (D), GST (E) and GSH (F) activity in control and experimental groups of rats. Values are ex-
pressed as mean ± SD. Means with the same letters are not signifi cantly diff erent at p<0.05.
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well as in group II, compared to other groups. Percentage 
of monounsaturated fatty acids (MUFA) statistically de-
creased in groups II and V compared to groups III and IV 
(p≤.). Analysis of polyunsaturated fatty acids (PUFA) 
profiles did not show differences in levels of precursors 
of n- and n- families, i.e. linoleic acid (LA, : n-) and 
alpha-linolenic acid (ALA, : n-) between examined 
groups, but there were statistical signifi cant diff erences in 
concentration of their metabolites in plasma phospholipids. 
Our results showed that lipogenic diet decreases percentage 
of arachidonic acid (AA, : n-) in III and IV group, while 
between other groups there were no differences. On the 
other hand, level of n- PUFA increased in groups II and V 
compared to I, III and IV group. Percentage of eicosapentae-
noic acid (EPA, : n-) increased in group V compared to 
other examined groups. Percentage of docosahexaenoic acid 
(DHA, : n-) statistically increased in control, compared 
to other groups, and did not diff er between groups II, III, IV 
and V. In this study ratio of n-/n- did not diff er between 
groups I, IV and V, while in groups II and III was statisti-
cally increased compared to control, and n- FA increased 
percentage could have negative consequences on health. 
Hepatic antioxidant activity
It could be observed that group III induced a signifi cant in-
crease (p<.) in the liver MDA levels compared to groups 
I and II (Figure ), resulting in the oxidative damage to 
the lipids. Th e activities of SOD (signifi cantly p<.) and 
GSH-Px (slightly) were decreased in the group III. Particu-
larly, the high XOD activity (p<.) was recorded in given 
group compared with all other experimental groups (Figure 
). Statistically the signifi cant increase (p<.) in the CAT 
activity was observed in the group III (Figure ) which indi-
cated that the CAT activity was one of the most important 
enzyme defenses against hydrogen peroxide formation, es-
pecially when there was no high activity of GSH-Px as it 
was detected in this group. As shown in Figure , the levels 
of GSH were signifi cantly decreased (p<.) in the group 
III. Furthermore, the significantly high (p<.) IC radi-
cal scavenger activity (the DPPH assay) was observed in this 
group (Figure ). The GST activity increased significantly 
(p<.) in the liver of the group III (Figure ) considering 
liver as the metabolic centre for the detoxifi cation []. Th e 
data presented in the Figure  show that there was no signifi -
cant diff erence in the MDA levels of the groups I and II in 
the comparison to the group IV. In other enzymatic and non 
enzymatic parameters of the antioxidative status no signifi -
cant diff erences were detected between the groups IV and V, 
except for the GSH-Px levels which were signifi cantly higher 
in the group V and nearly the same as in the groups I and 
II. It indicated a benefi cial eff ect of the buckwheat enriched 
diet. Although the GSH level in the groups IV and V didn’t 
show an increment in its level, IC (the DPPH assay) signifi -
cantly decreased (p<.) in both IV and V groups (Figure ). 
Morphological results
After  weeks of fat rich diet there was no change in aor-
tic intima specific for early atherosclerosis, although 
adipocytes of periaortic adipose tissue were somewhat 
enlarged and containing more fat in group III (Figure 
), compared to animals with regular diet (I group, Fig-
ure ). Histology of other organs remained normal. His-
tological findings of organs were normal in animals fed 
a regular and food enriched with BLF mixture (I and II 
group), after  week of the experiment (Figures  and ).
Significant changes were observed in liver of animals in 
III, IV and V group. Grossly, liver was enlarged, softer, yel-
lowish and greasy. Other examined organs had no gross 
changes. Pathohistological findings in liver specimens ob-
tained from HF groups of animals correlates with steato-
hepatitis: fatty degeneration of hepatocyte cytoplasm (ap-
proximately  of hepatocytes), mostly of microvesicular 
type, mild to moderate mononuclear inflammatory infil-
trate in portal tracts, groups of lymphocytes inside hepatic 
lobular parenchyme (lobular inflammatory activity) and 
rupture of endothelium in few central veins (Figures -). 
FIGURE 3.  Periaortic adipose tissue (III 
group), HE x 400.
FIGURE 4.  Periaortic adipose tissue ( I 
group), HE x 400.
FIGURE 5.  Normal architecture of hepatic 
parenchyme (I group), HE x 100.
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DISCUSSION
BLF mixture supplementation contributed to the de-
creased body weight gain when compared high-fat 
group, and such results get along with the stud-
ies reporting that polyphenols exert an inhibitory ef-
fect on growth by decreasing protein digestibility [].
It was supposed that the weights of the liver in the HF groups 
were increased by the high-fat diet. However, the kidney 
and brain weights were not signifi cantly diff erent between 
the groups (p<.). In our study, as well as in previously 
feeding experiments with rats [] was observed that cho-
lesterol, fat component and cholic acid addition to normal 
diet increase plasma cholesterol concentration, i.e. enhanc-
ing hyperlipidemic eff ect. TG, TC, LDL concentrations and 
AI were significantly lower in BLF mixture supplemented 
rats fed a high-fat diet, but this supplement had no eff ect in 
cholesterol-free diet groups. It has been reported that the 
hypocholesterolemic eff ect of dietary fi ber and polyphenolic 
compounds were more eff ective in hypercholesterolemic ani-
mals and humans than in normocholesterolemic ones []. 
FAs profiles in PL were determined after  weeks of the 
experiment. Palmitic acid raise plasma cholesterol, induce 
apoptosis in adult rat cardiomyocytes and has a dramatic 
destructive eff ect on the myofi brillar apparatus []. In con-
trast, stearic acid may have neutral or even positive eff ects on 
health because it has been shown to exert cardioprotective 
[] and cancer-protective eff ects []. Th erefore, BLF mix-
ture intake has benefi cial eff ects on SFA/ PL and health. Al-
though, oleic acid is considered benefi cial for health [], our 
results showed that hypocholesterolemic eff ect in group V is 
consequence of some other factors rather than oleic acid. AA 
is a precursor for the synthesis of leukotriene B, thrombox-
ane A, and prostaglandin E, as mediators of infl ammation 
[]. Low concentrations of AA is consequence of decreased 
level of n- fatty acids, and may cause infertility in both males 
and females [, ]. Also, decreased level of total PUFA, 
mainly of n- family, was observed in patients with insulin 
resistance []. BLF mixture intake increased percentage of 
n- PUFA in plasma PL of examined animals. Th ese fi ndings 
are very important, considering that n- PUFA are necessary 
for liver and kidney function, heart contractility, and skin per-
meability []. EPA is precursor of prostaglandin PGE- and 
leukotriene LTB-. It has the ability to partially block the con-
version of n- FA to harmful eicosanoids, thereby reducing 
the cardiovascular risk and inhibiting tumor genesis [, ]. 
Percentage of ALA did not diff er between examined groups, 
supposing BLF mixture intake increase enzyme activity in 
FIGURE 6.  Normal architecture of hepatic 
parenchyme (II group), HE x 100.
FIGURE 7.  Moderate mononuclear infl am-
matory infi ltrate in portal tract (III group), HE 
x 400.
FIGURE 8.  Fatty change of centrolobular 
hepatocytes, mostly microvesicular type (III 
group), HE x 400
FIGURE 9.  Endothelial rupture of central 
vein (III group), HE x 400.
FIGURE 10.  Fatty change in hepatocyte cy-
toplasm with focus of lobular infl ammatory 
activity (IV group), HE x 400.
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EPA biosinthesys. DHA plays the important role in neural 
and retinal development, may protect against Alzheimer 
disease [] while defi ciency in n- PUFA may be associated 
with metabolic syndrome in adults []. For optimal human 
nutrition, the ratio of n-/n- must not be higher than  
[]. Th e results presented in this study demonstrated that 
supplementation of BLF mixture improved FAs profi les in 
rats with induced hypercholesterolemia, decreasing percent-
age of palmitic acid and SFA, and by increasing percentage 
of stearic acid and total PUFA, compared to control group. 
Low percentage of oleic acid in animals which consumed BLF 
mixture could be improve by addition of olive oil in usual diet.
Th e activity of enzymes, such as CAT, SOD, XOD, GSH-Px, 
GST, were measured to determine the antioxidant activity in 
vivo. Th e MDA, GSH and DPPH levels were also measured in 
this study, after  weeks of the experiment. Feeding a high-
fat diet resulted in a large amount of fat intake and a further 
increment of PUFA in the liver susceptible to the lipid per-
oxidation. Th e resent study [, ] stated that the increased 
levels of MDA in the hyperlipidemic rats could be attributed 
to the increased ROS production and/or the defi ciency of 
the antioxidant defence system. High amount of the XOD 
activity in the group III resulted in the high amount of the 
hydrogen peroxide content. BLF enriched diet could be a 
good choice for lowering the MDA levels in the hyperlipid-
emic animals. We assume that this results indicates that the 
antioxidant eff ect of the BLF enriched food may depend on a 
diff erent phenolic content (high level of rutin and quercetin), 
which may provide a mechanism for the buckwheat pharma-
cological activity. Th e consumption of the BLF enriched food 
both by the groups IV and V resulted in the return of the an-
tioxidant protection to the level of the normal state (to the 
levels of the control and the buckwheat groups). Accordingly, 
the signifi cant decrease (p<.) of GST, CAT and XOD ac-
tivities were recorded in the cited groups in comparison to 
the group III in this study. Th e signifi cant increased (p<.) 
of the SOD activity in the liver homogenates of the hyper-
lipidemic rats fed a BLF enriched food was detected, con-
fi rming the good antioxidant status in the groups IV and V.
There were no differences in histological findings be-
tween HF groups of animals. Our morphological find-
ings correlate with findings of other authors [].
CONCLUSIONS
Th is study showed that the supplementation of the BLF mix-
ture significantly reduced body weight gain, plasma lipid 
concentrations and atherogenic index in rats fed a high-fat 
diet. An effi  cacy of lipid-lowering action of the BLF mixture 
indicates that these parts of the plant with the highest rutin 
content have anti-hyperlipidemic eff ect and could be benefi -
cial for regulation of lipid metabolism or prevention of hyper-
lipidemia. Treatment with BLF in fat-fed groups increased 
percentage of n- FA and EPA, decreased percentage of SFA, 
MUFA (oleic acid) and partly AA. Considering our results 
buckwheat should be consume with olive oil in usual diet 
habits, but future studies should addressed it. Th e obtained 
results of the hepatic antioxidant status of hyperlipidemic rats 
are consistent with the assumption that the buckwheat an-
tioxidant eff ects aff ect the body’s antioxidant status and the 
liver, as the central metabolic organ, in a favourable way to di-
minish the negative infl uence of a high-fat diet consumption. 
Fat rich diet induced gross and histological changes of liver 
typical of steatosis and steatohepatitis, without signifi cant 
resolution following supplementation of the BLF mixture. 
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